SEC Filings
T. Rowe Price Reports 16.6% Passive Stake In Beta Bionics, 13G Shows
The filing lists 8,943,061 shares, with a health sciences fund holding a slice, as a securities class action against the company is pending.
SEC Filings
The filing lists 8,943,061 shares, with a health sciences fund holding a slice, as a securities class action against the company is pending.
SEC Filings
The Supervisory Board unanimously chose Shervin Korangy to succeed Helen Giza, with the switch taking effect October 12.
SEC Filings
The filing lists 13,935,185 shares, with SSGA Funds Management holding 1.5% of the class and no sole voting power at either filer.
SEC Filings
A Schedule 13G puts 1,161,421 Innospec shares under Allspring's investment advisers, with a certification of no intent to influence control.
SEC Filings
A Schedule 13G filed Wednesday lists FMR and Abigail P. Johnson as reporting persons, with FMR holding sole voting power over most shares.
SEC Filings
The Fidelity parent holds 19,006,368.57 shares as of September 30, and says it has no aim to influence control.
SEC Filings
The proxy shows three Dorrance descendants with large stakes ahead of a November 17 vote the board opposes.
SEC Filings
The 8-K says Prerna Sachdeva's exit involved no disagreement with the company, and Cassandra Hudson will fill in at no extra pay.
SEC Filings
Tom Lee's Wednesday presentation, furnished in an 8-K, says Bitmine is about 100,000 ETH short of its 5% supply goal.
SEC Filings
The board treated Bishop's exit as a termination without cause; Latino's base salary is $460,000 plus a $120,000 sign-on bonus.
SEC Filings
The board grew from nine to 10 seats, and the new independent director joins two committees, according to an 8-K.
SEC Filings
An 8-K says the sale funds a late-stage SPY072 program in hidradenitis suppurativa, with closing expected on or about Wednesday.